This prostate cancer study used Terra to process exome sequencing and single-cell RNAseq data with automated workflows.


This cancer drug discovery study used Terra to process transcriptome profiling data with TOPMED RNA-Seq workflows.


Brendan Reardon, computational biologist at Dana Farber Cancer Institute, describes how the MOAlmanac algorithm and analysis portal enable a wide range of users to leverage large-scale genomics to guide individualized patient care in oncology.

White_blood_cell_cancer (1)

PANOPLY is a computational framework for applying statistical and machine learning algorithms to transform multi-omic data from cancer samples into biologically meaningful and interpretable results. In this post, D. R. Mani explains how his team is leveraging Terra to make PANOPLY accessible to a wide range of researchers.

Stay informed and get involved

To see all blog posts, visit our
Archive page


Follow us on Twitter